Human papillomavirus type 33 (HPV-33) pseudovirus infection is a slow process dependent on the initial interaction with cell-surface heparan sulfate (T. Giroglou, L. Florin, F. Schafer, R. E. Streeck, and M. Sapp, 2001a , J. Virol. 75, 1565-1570. We have now further dissected the initial steps of pseudovirus uptake using removal of cell-surface proteoglycans and selective inhibition of entry pathways. Treatment of cells with heparinase I, but not with phosphoinositol-specific phospholipase C (PIPLC), prevented binding of papillomavirus-like particles and infection with HPV-33 pseudovirions, indicating that GPI-linked proteoglycans (glypicans) are not required for productive infection. The slow entry of pseudovirions was inhibited by cytochalasin D and nocodazole in a concentration-dependent manner, suggesting actin polymerization and intact microtubuli be required. Inhibitors of the caveolae-mediated uptake did not significantly affect pseudoinfection. Interestingly, pseudoinfection was blocked by selective inhibitors of endosomal acidification up to 12 h postinfection. Together, our results suggest that binding of HPV pseudovirions to heparan sulfate proteoglycans, most likely syndecans, is followed by delayed internalization via the endosomal pathway. © 2002 Elsevier Science (USA)
INTRODUCTION
Papillomaviruses are nonenveloped epitheliotropic viruses exclusively replicating in keratinocytes of the skin and mucosa. Their DNA genome of approximately 8000 bp is encapsidated by the major and minor capsid proteins, L1 and L2. Although the etiological role of human papillomavirus (HPV) in the development of cervical intraepithelial neoplasia and invasive cancer is well established, the initial steps of HPV infections are far from being understood. Due to difficulties in generating papillomaviruses in vitro, most investigations addressing virus-receptor interactions were restricted to binding studies with virus-like particles (VLPs), and the identity of putative HPV-specific receptor proteins is still quite controversial. By binding studies, attachment of HPV-6 VLPs to the alpha-6 integrin was reported and it was proposed that this integrin may act as a general receptor for binding and entry of papillomaviruses (Evander et al., 1997; McMillan et al., 1999) . However, other groups have shown alpha-6 integrin to be dispensable for HPV-11 VLP binding to cells (Joyce et al., 1999) , for bovine papillomavirus type 4 (BPV-4) infection (Sibbet et al., 2000) , as well as for HPV-16 and HPV-33 pseudoinfection (Giroglou et al., 2001a) . VLPs of HPV-11 were shown to bind to heparin and to cell-surface proteoglycans of keratinocytes and Chinese hamster ovary cells via heparan sulfate (Joyce et al., 1999) . Since cell-surface proteoglycans bind to a large number of proteins, their molecular interactions have long been considered nonspecific. This perception was challenged in recent years by a growing body of evidence demonstrating that heparan sulfate interactions with ligands depend on specific sequences and positioning of heparan sulfate moieties (Park et al., 2000) .
Heparan sulfate proteoglycans (HSPGs) consist of heterogeneously sulfated unbranched polysaccharides composed of repeating disaccharide subunits of hexuronic acid and hexosamine, covalently linked to the proteoglycan core through O-glycosidic linkages to serine residues. Although HSPGs are ubiquitously distributed within the extracellular matrix of most tissues and located on the cell surface of most cells, their expression is highly regulated and cell type and developmental stage-specific. Glypicans and syndecans are the major subfamilies of cell-surface HSPGs. Glypicans contain a glycosyl-phosphatidyl-inositol (GPI) anchor, whereas syndecans, the transmembrane group of HSPGs, are physically connected with cytoskeletal components and play important roles in signal transduction (Park et al., 2000) . Moreover, syndecans function as specific growth factor receptors and are involved in cell-cell adhesion. Interestingly, they also regulate proteolytic and lipolytic pathways and can directly mediate the internalization of lipoproteins and other ligands through a noncoated pit pathway. This HSPG-mediated pathway involves cluster-ing of proteoglycans in detergent-insoluble membrane rafts (David, 1993; Carey, 1997; Williams and Fuki, 1997) .
Using pseudovirions encapsidating a marker plasmid coding for a dimeric green fluorescent protein fused to a nuclear localization signal (GFP-NLS), we recently provided evidence that cell-surface HSPGs are not only involved in HPV binding but are also necessary for infection with HPV (Giroglou et al., 2001a) . In the present investigation we further specified the family of proteoglycans required for HPV binding and examined the putative intracellular trafficking pathway used by HPV pseudovirions for productive infection by applying specific inhibitors.
RESULTS

Glypicans are not required for HPV binding and infection
We first assessed if both transmembrane HSPGs (syndecans) and GPI-linked HSPGs (glypicans), which are linked to the external leaflet of the membrane through a GPI moiety, do play a role in HPV binding. COS-7 cells were either treated with heparinase I, phosphoinositolspecific phospholipase C (PIPLC), or left untreated prior to the exposure to HPV-33 L1L2 VLPs. Cell-bound VLPs were visualized by Western blot analysis using the HPV capsid protein L1-specific monoclonal antibody 33L1-7 (Fig. 1A) . General removal of glycosaminoglycans by treatment of cells with heparinase I resulted in a drastic decrease in VLP binding, confirming the previously reported involvement of heparan sulfate in HPV host cell interactions (Joyce et al., 1999; Giroglou et al., 2001a) . In contrast, specific removal of GPI-linked glypicans by hydrolysis of phosphatidylinositol with PIPLC did not significantly affect VLP binding, suggesting that glypicans are not the key players in HPV host-cell interactions. Corresponding results were obtained in VLP-binding assays using human cervical epithelial HeLa cells (data not shown). Activities of the applied reagents were controlled by FACS analysis. Removal of cell-surface HSPGs after treatment with heparinase I was monitored using the heparan sulfate specific monoclonal antibody F58-10E4 (Fig. 1B) . As judged by comparison of mean fluorescence data, cell-surface expression of HSPG on COS-7 was more than twofold lower than that of most HeLa cells. These heparan sulfate moieties on the cell surface were completely removed by treatment with heparinase I on COS-7 cells and significantly reduced on HeLa cells. Due to the lack of glypican-specific antibodies, cleavage of GPI-linked glypicans and other GPIlinked proteins by PIPLC was controlled by measuring the cell-surface presentation of DAF/CD55 proteins. Digestion with PIPLC (1 unit/ml) resulted in complete removal of these GPI-anchored proteins from COS-7 and HeLa cells (Fig. 1C) . The influence of heparinase and PIPLC treatment on HPV-33 pseudovirus infections is demonstrated in Fig. 1D . One hour prior to infection with pseudovirions, cells were pretreated with heparinase I or PIPLC. Correlating with the VLP binding study (Fig. 1A) , pseudovirus infection of COS-7 cells was completely abolished by digestion of cell-surface HSPGs with heparinase I but was not affected by removal of GPI-linked glypicans with PIPLC.
Analysis of the pseudovirus pathway of infection
Transmembrane HSPGs, in particular syndecans, have previously been shown to directly mediate binding, internalization, and lysosomal delivery of certain ligands through a largely uncharacterized, coated pit-independent pathway . To investigate the mechanism of HPV internalization, COS-7 cells were infected with HPV-33 pseudovirions in the presence of various pathway-specific inhibitors. Previous postattachment neutralization experiments by Giroglou et al. (2001a) had shown that internalization of HPV pseudovirions is a very slow process. Cell-surface-bound virions were still accessible to heparin and neutralizing antibodies several hours after addition of pseudovirions to cells. Significant inhibition of such slow internalization requires prolonged exposure to specific inhibitors. Since many inhibitors of internalization and cell regulation are rather cytotoxic and cannot be applied for 20 h or more, we used three different time windows for the application of inhibitors of HPV internalization and infection. As shown in the schematic diagram in Fig. 2A , inhibitors were applied for 6-h intervals from 0-6, 3-9, and 6-12 h postinfection (p.i.), covering the early phase of pseudovirus infection. With this assay, infectious events in the presence or absence of inhibitors can be monitored by fluorescence microscopy at 48-72 h p.i., counting cells with nuclear green fluorescence due to expression of the pseudovirus-encoded GFP-NLS protein (Fig. 2B ). After removal of inhibitors at the defined time points, residual virions can be neutralized by addition of HPV-specific K53 antibodies to restrict pseudovirus entry to the investigated time interval.
Slow uptake of pseudovirions depends on actin-polymerization
Interaction with the actin network is a characteristic feature of the syndecan group of HSPGs, and internalization of ligands via syndecan-1 was reported to be dependent on an intact actin cytoskeleton . We therefore investigated the effect of cytochalasin D, a potent inhibitor of microfilaments (Miranda et al., 1974) , on HPV pseudovirus infection. As shown in Fig. 3A , dose-dependent inhibitory effects were observed with cytochalasin D present at 0.5, 1, and 5 M concentrations. When the actin network was depolymerized as late as 6-12 h p.i., a dose-dependent inhibitory effect on infectivity was still observed, confirming the unusually slow kinetics of pseudovirus internalization. Although the effect of cytochalasin D was not as pronounced as 0-6 or 3-9 h p.i., pseudoinfection was still reduced by 78% when cells were treated with 5 M cyto D. These data demonstrate that the actin network plays a critical role in the early steps of HPV pseudovirus infection.
Pseudovirus infection requires intact microtubuli
Recent electron microscopy data (Liu et al., 2000) demonstrated the association of bovine papillomavirus-1 (BPV-1) virions with microtubules in the cytoplasm of infected cells. To investigate the role of a putative microtubule-mediated transport of HPV-33 pseudovirions, COS-7 cells were treated with the microtubule-disrupting agent nocodazole at 0-6, 3-9, and 6-12 h p.i. In all three time windows tested, 5-20 M concentrations of nocodazole were found to significantly affect pseudovirus infectivity (Fig. 3B) . In contrast to the early effect of the actin inhibitor cytochalasin D, treatment with the microtubuli-depolymerizing drug nocodazole seemed to be most effective at 3-9 and 6-12 h p.i. These data indicate that intact microtubuli are required up to the late steps of pseudovirus entry.
Treatment with Nystatin does not impair pseudovirus infection
Until recently (Murphy, 1996) papillomaviruses, polyomaviruses, and simian virus 40 (SV40), now belonging to sep- arate virus families, were all grouped into the Papovaviridae family. The uptake of mouse polyomavirus as well as the slow entry of SV40 were both shown to occur via caveolae (Anderson et al., 1996; Richterova et al., 2001) . Productive infection with SV40 was inhibited in the presence of cholesterol-depleting drugs, such as nystatin or PMA (Anderson et al., 1996) . In contrast to infections by members of the family Polyomaviridae, HPV-33 pseudoinfection is not significantly affected by inhibitors of the caveolae pathway, as shown by the infection inhibition assay presented in Fig.  3C . In the presence of nystatin at concentrations of 5, 10, and 20 M, only a weak dose-dependent effect on HPV pseudoinfections was observed in one of the three tested time windows, at 3-9 h p.i. However, infection was not reduced by more than 35% (Fig. 3C) . At 0-6 and 6-12 h p.i. pseudovirus infection was not prevented by the inhibitor concentrations tested. Similar results were obtained in the presence of the phorbol ester PMA, used at concentrations of 1, 5, and 10 M. In contrast to its minimal effect on HPV infection, the presence of such concentrations of nystatin and phorbol myristic acid significantly affected our infections of HeLa cells with Echovirus 1 (data not shown), a virus recently demonstrated to be internalized via caveolae (Marjomaki et al., 2002) . Therefore, it is unlikely that caveolae contribute significantly to productive HPV internalization. 
Pseudovirus infection is blocked by bafilomycin A1
Ligands that are taken into cells by receptor-mediated endocytosis are sorted somewhere in between early to late endosomes. Infectious entry of most viruses that use this endocytic pathway requires acidification of late endosomes by vacuolar ATPases to trigger conformational changes in the capsid structure for release of their genome into the cytosol or perinuclear area. These ATPases are effectively inhibited by the fungal drug bafilomycin A1 (BFLA1). During the first 6 h p.i., as low as 50 nm (0.05 M) concentrations of BFLA1 were already sufficient to completely prevent HPV pseudovirus infection (Fig. 4A) . General toxic effects on pseudovirions or host cells, caused by the highest concentration (5 M) of BFLA1, were determined in separate experiments to be in the range of less than 15% (data not shown), confirming the specificity of this endosomal inhibitor. In good correlation with the slow kinetics of pseudovirus uptake, infectivity at 3-9 and 6-12 h p.i. was still reduced in the presence of BFLA1 from 90% (0.05 M) up to 98% (5 M), suggesting that HPV pseudovirions are slowly internalized via the endosomal/lysosomal pathway and dependent on endosome acidification. 
Lysosomotropic weak bases prevent pseudovirus infection
In addition to the well-established inhibitory effect on endosome acidification, BFLA1 was also reported to affect infectivity of some viruses by trapping of the virus in endosomal subcompartments which lack components necessary for viral uncoating (Bayer et al., 1998) . To further investigate whether a low pH in endocytic vesicles is really necessary for productive pseudovirus infection, lysosomotropic weak bases were added to the infection assay to raise the vesicular pH. A dose-dependent inhibition of infection was observed in the presence of chloroquine present from 0-6, 3-9, and 6-12 h p.i. at nontoxic concentrations in the range from 5 to 25 M (Fig. 4B) . As shown in Fig. 4C , similar results were obtained by treatment of infected cells with excessive concentrations (5, 10, and 20 mM) of the lysosomotropic agent ammonium chloride (NH 4 Cl). We conclude from these studies that HPV-33 pseudovirions employ the endosomal pathway and require endosomal acidification for productive infection.
DISCUSSION
Viruses can enter cells on various internalization pathways, and this variation may largely depend on the interactions with primary attachment receptors. We and others have previously shown that cell-surface heparan sulfate is the primary attachment receptor for HPV and crucial for pseudovirus infectivity (Joyce et al., 1999; Giroglou et al., 2001a) . Since treatment of cells with heparinase I, but not with PIPLC, abolishes pseudovirus infection, heparan sulfates of the transmembrane group rather than GPI-linked glypicans seem to be required for the initiation of productive infection. The data presented in this article further suggest that after primary attachment to proteoglycans, HPV-33 pseudovirions are internalized into the endosomal/lysosomal compartment. Some years ago, Müller et al. (1995) had reported that the uptake of HPV VLP-reporter plasmid complexes was enhanced in the presence of replication-defective adenoviruses, possibly due to adenovirus-mediated lysis of lysosomal membranes. Analyzing the effects of various inhibitors in our HPV-33 pseudoinfection system, we could show that HPV infection is prevented in the presence of compounds that raise the pH in endosomes, such as BFLA1, chloroquine, or NH 4 Cl, demonstrating that acidification of endosomal vesicles is important for the release of virions into the cytosol. Energy depletion by addition of both 0.1% sodium acid (NaN 3 ) and 50 mM 2-desoxy-D-glucose also completely abolishes infection (data not shown), corroborating the uptake of pseudovirions via the energy-dependent endosomal pathway.
Our studies with nocodazole demonstrate the requirement of intact microtubules for pseudovirus infectivity. It was recently reported that nocodazole blocks nuclear trafficking of BPV-1 when added up to 30 min after virus binding (Liu et al., 2000) . In contrast to the data with BPV-1, HPV-33 pseudovirius infection was sensitive to microtubuli-depolarization as late as 6-12 h p.i., indicating that pseudovirions are still transported from endosomes to the nucleus at that time. These data correlate with the slow uptake and long accessibility of pseudovirions on the cell surface (Giroglou et al., 2001a) as well as with the slow infection kinetics of HPV-11, BPV-1, and CRPV (Christensen et al., 1995) . This delay in the uptake of HPV pseudovirions may be attributed to their initial interactions with proteoglycans and slow conversion from a heparin-sensitive to a heparin-resistent state of binding.
Interestingly, Fuki et al. (1997) have previously demonstrated that syndecans are able to directly mediate endocytosis of certain multimeric ligands by a novel, largely uncharacterized pathway independent of caveolae and coated pits. Such a syndecan-mediated entry proceeds with a half-time of internalization of about 1 h and is dependent on interactions with the actin cytoskeleton. Our observation of inhibitory effects mediated by cytochalasin D in the pseudovirus infection assay would be consistent with syndecan-mediated internalization. The delayed uptake, however, is unusual for syndecan-mediated direct internalization and would rather suggest the involvement of a secondary receptor protein. Although we only provide indirect evidence for a role of syndecans in HPV binding and uptake, we still consider this group of proteoglycans as the prime candidate receptors for productive infection with HPV. However, we cannot completely exclude the involvement of other, less-characterized HSPGs, such as perlecans or betaglycans. The slow kinetics of pseudovirus internalization would also correlate with the time course of perlecan internalization but is inconsistent with its sensitivity toward treatment with cytochalasin D. Regarding betaglycans, which are modulators of the TGF-beta actions, direct internalization of ligands has not been described so far. Based on our data, it is tempting to speculate that a syndecan-mediated internalization of pseudovirions may join the endosomal pathway at the stages of early to late endosomes. Such syndecan-mediated entry pathways are still under investigation . However, the existence of viral entry mechanisms other than via the established pathways was recently demonstrated studying the new two-step vesicular transport pathway of SV40 (Pelkmans et al., 2001) . Initial entry of SV40 via caveolae delivered the virus into a new organelle, termed caveosome, where the virus stayed for several hours until microsome-dependent transport to the perinuclear area occured.
In accordance with our data, it is also conceivable that attachment of HPV pseudovirions is followed by transfer to a secondary receptor which subsequently mediates delayed internalization via receptor-mediated endocyto-sis. This would be consistent with the idea that syndecans primarily function as modulators or facilitators of cell-ligand interactions. Many structurally different viruses and certain microbial agents have previously been shown to utilize sulfated glycosaminoglycans, such as heparan sulfate, for initial binding to target cells, but most of these viruses require additional proteins for internalization (Shieh et al., 1992; Compton et al., 1993; Rostand and Esko, 1997; Shukla et al., 1999; Hilgard and Stockert, 2000; Akula et al., 2001) . A transfer of HPV pseudovirions from the primary HSPG receptor to a secondary receptor protein is also supported by the finding that the minor capsid protein L2 is not required for initial virus binding to proteoglycans but is important for virus infectivity (Unckell et al., 1997; Kawana et al., 1998) . Kawana et al. (2001) recently reported specific binding and internalization of a L2-GFP fusion protein into HPVsusceptible cells and postulated the presence of L2-specific cell-surface receptors, different from those for L1. The HPV capsid contains 360 copies of L1 but only about 12 copies of L2 (Sapp et al., 1995; Trus, 1997) . HPV infection may therefore require specific virus sequestration by proteoglycan attachment receptors for efficient presentation of certain L2 domains to a secondary receptor protein which may subsequently deliver the virus to the classical endosomal pathway.
MATERIALS AND METHODS
Cell lines and chemicals
COS-7 and HeLa cells were grown in monolayers in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum. If not stated otherwise, all chemicals were obtained from Sigma. Stock solutions of cytochalasin D (4 mM), nocodazole (10 mM), nystatin (5 mM), PMA (10 mM), and bafilomycin A1 (10 M) were prepared in dimethyl sulfoxide (DMSO). The final concentration of DMSO, which was also added to control samples, was kept below 1%. Stock solutions of chloroquine (10 mM) and ammonium chloride (400 mM) were dissolved in DMEM and adjusted to pH 7.
VLP binding assay
HPV33 L1/L2 virus-like particles, produced by infection of insect SF9 cells with recombinant baculoviruses, were prepared essentially as described by Volpers et al. (1994) . COS-7 cell monolayers (5 ϫ 10 5 cells) were exposed to 70 ng HPV33 L1/L2 VLPs in DMEM for 1 h at 4°C. Unbound VLPs were removed by three washes with PBS; cells were lysed in Laemmli sample buffer and subjected to sodium dodecyl sulfate-polyacrylamid gel electrophoresis (SDS-PAGE). After blotting onto nitrocellulose membrane, cell-surface-bound HPV L1 protein was detected by ECL Western blot analysis using monoclonal antibody 33L1-7 and horseradish peroxidase-conjugated secondary antibodies.
Removal of cell surface proteoglycans
Heparan sulfate proteoglycans were removed from the cell surface of COS-7 and HeLa cells by treatment with heparinase I (Sigma). Cells were grown to 80% confluency in six-well plates, washed with DMEM without FCS, and incubated with 2 units of heparinase I for 60 min at 37°C in heparinase I buffer (20 mM Tris-HCl, 50 mM NaCl, 4 mM CaCl 2 , 0.01% BSA, pH 7.5). GPI-linked HSPGs (glypicans) and GPI-linked DAF/CD55 proteins were released from the cell surface by treatment with phosphoinositol-specific phospholipase C (1 unit/ml DMEM) for 60 min at 37°C.
Flow cytometry
Prior to processing for FACS analysis, cells were pretreated with heparinase I or PIPLC as described above and detached with 25 mM EDTA in Ca 2ϩ -and Mg 2ϩ -free PBS. Single-cell suspensions (5 ϫ 10 5 cells) were fixed for 10 min with 3.7% formaldehyde-PBS and incubated on ice with primary antibodies for 30 min. Cell-surface HSPGs were detected with the anti-heparan sulfate IgM antibody F58-10E4 (10 g/ml; Seikagaku Corp., Japan), followed by a 30-min incubation on ice with Cy2-labeled antimouse IgM and IgG. Removal of GPI-linked proteins by PIPLC was analyzed by measuring the expression levels of the GPI-linked DAF protein. Cells were exposed to the anti-DAF monoclonal antibody IF7 (obtained from Jeff Bergelson, Philadelphia, PA) and subsequently incubated with FITC-labeled anti-mouse IgG. Cells were washed in FACS buffer (PBS-1% BSA-5 mM EDTA-0.01% NaN 3 , pH 6.8), analyzed in a FACSCalibur (Becton-Dickenson) flow cytometer, and evaluated using either CellQuest or WinMDI 2.8 software.
HPV pseudovirus infection assay
HPV-33 pseudovirions, containing the GFP-NLS encoding plasmid, were basically prepared as published recently (Giroglou et al., 2001b) . COS-7 cells were grown in 24-well plates (5 ϫ 10 4 cells/well) and infected with pseudovirions in a total volume of 250 l PBS-100 g/ml BSA, pH 6.8. After 1 h at 4°C the pseudovirions were replaced by 1 ml supplemented culture medium. Subsequently, cells were grown for 72 h at 37°C before infectious events were determined by counting cells with nuclear green fluorescence.
Inhibition of infection
To characterize postadsorption steps leading to infectious entry of HPV-33 pseudovirions, infections were per-formed in the presence of pathway-specific inhibitors. Cytochalasin D, nocodazole, nystatin, PMA, bafilomycin A1, chloroquine, and ammonium chloride were applied for 6 h intervals from 0-6, 3-9, and 6-12 h p.i. As for the 0-6 h time interval, inhibitors were present during a preincubation period of 30 min at 37°C prior to virus addition, during virus attachment for 1 h at 4°C, as well as during the following 6 h at 37°C, to cover the very early events of putative virus internalization. For assessment of inhibitory effects during 3-9 and 6-12 h p.i., cells were initially cultured in medium without inhibitors, and chemicals were added at the start of the indicated time intervals and removed after 6 h by replacement of culture media. Virions remaining on the cell surface at the end of the investigated time intervals were neutralized by addition of HPV-specific K53 antibodies (1:300 dilution). GFPpositive cells were already visible at 48 h p.i. and continuously monitored from 48 to 96 h p.i. For evaluation of inhibitory effects, pseudovirions produced in the presence and absence of inhibitors were counted at 72 h p.i.
